News

Filter

Current filters:

bluebird bioOncology

bluebird bio in multi-million dollar oncology deal with Celgene

22-03-2013

In a second licensing accord this month, US biotech firm Celgene Corp (Nasdaq: CELG) has signed a strategic…

Biotechnologybluebird bioCelgeneLicensingOncology

Back to top